MEAC
GSK icon

M.E. Allison & Co’s GSK GSK Stock Holding History

M.E. Allison & Co’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$368K Hold
7,017
– – 0.21% 123
2026
Q1 		$387K Hold
7,017
– – 0.26% 106
2025
Q4 		$344K Sell
7,017
-1,600
-19% -$74.6K 0.23% 111
2025
Q3 		$372K Sell
8,617
-2,653
-24% -$104K 0.26% 106
2025
Q2 		$433K Buy
11,270
+484
+4% +$18.5K 0.35% 75
2025
Q1 		$418K Buy
10,786
+1,500
+16% +$54.9K 0.41% 72
2024
Q4 		$314K Buy
+9,286
New +$334K 0.35% 86

Other funds holding GSK

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
KFP
Keystone Financial Planning Cleveland, Ohio $388M AUM 16.66% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
GC
Grimes & Company Westborough, Massachusetts $4.62B AUM 29.71% 1-Year Est. Return
BB
Bell Bank Fargo, North Dakota $2.62B AUM 23.93% 1-Year Est. Return
KIC
Keating Investment Counselors Delray Beach, Florida $364M AUM 22.11% 1-Year Est. Return
GHAM
Gilman Hill Asset Management New Canaan, Connecticut $731M AUM 19.41% 1-Year Est. Return
AWAG
ARS Wealth Advisors Group St. Petersburg, Florida $1.28B AUM 24.51% 1-Year Est. Return
HAI
Hennessy Advisors Inc Novato, California $3.13B AUM 77.26% 1-Year Est. Return

M.E. Allison & Co's GSK Position: Q2 2026 in Review

M.E. Allison & Co held its GSK (GSK) position steady in Q2 2026 at 7,017 shares worth $368K. The position accounts for 0.21% of the portfolio, ranked #123.

M.E. Allison & Co first reported a position in GSK in Q4 2024 and has held it in 7 quarters since. The position peaked at $433K in Q2 2025. 161 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • M.E. Allison & Co held 7,017 shares of GSK worth $368K as of Q2 2026.
  • M.E. Allison & Co left its GSK share count unchanged in Q2 2026.
  • GSK made up 0.21% of M.E. Allison & Co's portfolio in Q2 2026, its #123 holding.
  • M.E. Allison & Co first reported a position in GSK in Q4 2024 and has held it in 7 quarters since.
  • M.E. Allison & Co's GSK position peaked at $433K in Q2 2025.
  • 161 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on M.E. Allison & Co's 13F filing for Q2 2026, filed 7 Jul 2026.